Laser-induced optical breakdown is a prior strategy for acquired melanin-increased disorder in dermal layer

Lasers Med Sci. 2024 Aug 14;39(1):216. doi: 10.1007/s10103-024-04170-4.

Abstract

This brief report discusses the challenges in treating dermal melanosis and the limitations of current laser treatments due to inadequate tissue penetration and potential side effects. It introduces laser-induced optical breakdown (LIOB) as a novel therapeutic approach using a picosecond laser with a diffractive lens array (DLA) to target dermal pigmentation effectively. LIOB induces multiphoton ionization, leading to melanin clearance through phagocytosis and apoptotic cell removal, while also promoting dermal remodeling and collagen synthesis. We present a case of successful treatment of dermal pigmentation in a 55-year-old woman using 755 nm-picosecond alexandrite laser therapy, demonstrating significant improvement without recurrence. The findings suggest that LIOB offers a promising solution for acquired dermal hypermelanosis by addressing both diffuse and localized pigmentation effectively, leading to skin rejuvenation with minimal downtime and high patient satisfaction.

Keywords: Acquired hypermelanosis; Dermal hyperpigmentation; Laser-induced optical breakdown; Picosecond laser.

Publication types

  • Case Reports

MeSH terms

  • Female
  • Humans
  • Lasers, Solid-State* / therapeutic use
  • Low-Level Light Therapy / instrumentation
  • Low-Level Light Therapy / methods
  • Melanins / metabolism
  • Melanosis / radiotherapy
  • Melanosis / therapy
  • Middle Aged
  • Rejuvenation

Substances

  • Melanins